Does METOPROLOL Cause Atrial septal defect? 207 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 207 reports of Atrial septal defect have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.5% of all adverse event reports for METOPROLOL.
207
Reports of Atrial septal defect with METOPROLOL
0.5%
of all METOPROLOL reports
10
Deaths
23
Hospitalizations
How Dangerous Is Atrial septal defect From METOPROLOL?
Of the 207 reports, 10 (4.8%) resulted in death, 23 (11.1%) required hospitalization, and 7 (3.4%) were considered life-threatening.
Is Atrial septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 207 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Atrial septal defect?
ONDANSETRON (419)
LAMOTRIGINE (402)
VENLAFAXINE (348)
PAROXETINE (322)
SERTRALINE (304)
QUETIAPINE (275)
LEVETIRACETAM (246)
FLUOXETINE (235)
CITALOPRAM HYDROBROMIDE (204)
ESCITALOPRAM OXALATE (169)
Which METOPROLOL Alternatives Have Lower Atrial septal defect Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE